Why are influenza vaccine strains selected months before the flu season begins?
Influenza vaccine strains are selected months in advance to allow time for the analysis of global surveillance data, which tracks how influenza viruses evolve through a process called antigenic drift.1
Experts from the World Health Organization and various National Influenza Centers meet during this period to determine which specific strains are most likely to circulate during the upcoming season. This lead time is essential because the manufacturing process is complex, requiring the production of vaccine components that must be ready for distribution before the respiratory disease season begins in the fall.1234
While this proactive selection process is vital for public health, it carries the risk of a "mismatch" if a new viral variant emerges after the strains have been chosen. Nevertheless, even in cases of mismatch, the vaccine remains a critical tool, as it typically provides significant protection against severe illness, hospitalization, and death.1